BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28826091)

  • 1. Carapax Trionycis extracts inhibit fibrogenesis of activated hepatic stellate cells via TGF-β1/Smad and NFκB signaling.
    Hu Z; You P; Xiong S; Gao J; Tang Y; Ye X; Xia Y; Zhang D; Liu Y
    Biomed Pharmacother; 2017 Nov; 95():11-17. PubMed ID: 28826091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bioactive peptide of Carapax Trionycis on TGF-β1-induced intracellular events in hepatic stellate cells.
    Tang Y; Hu C; Liu Y
    J Ethnopharmacol; 2013 Jun; 148(1):69-73. PubMed ID: 23583903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference.
    Jiang Y; Wang C; Li YY; Wang XC; An JD; Wang YJ; Wang XJ
    J Ethnopharmacol; 2014 Dec; 158 Pt A():230-8. PubMed ID: 25456431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puerarin, isolated from Pueraria lobata (Willd.), protects against hepatotoxicity via specific inhibition of the TGF-β1/Smad signaling pathway, thereby leading to anti-fibrotic effect.
    Xu L; Zheng N; He Q; Li R; Zhang K; Liang T
    Phytomedicine; 2013 Oct; 20(13):1172-9. PubMed ID: 23856441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway.
    Dong Z; Gao Q; Guo H
    DNA Cell Biol; 2018 Mar; 37(3):227-232. PubMed ID: 29327938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro.
    Tang LX; He RH; Yang G; Tan JJ; Zhou L; Meng XM; Huang XR; Lan HY
    PLoS One; 2012; 7(2):e31350. PubMed ID: 22363627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
    Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β1-elevated TRPM7 channel regulates collagen expression in hepatic stellate cells via TGF-β1/Smad pathway.
    Fang L; Huang C; Meng X; Wu B; Ma T; Liu X; Zhu Q; Zhan S; Li J
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):335-44. PubMed ID: 25150141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.
    Choi YJ; Kim DH; Kim SJ; Kim J; Jeong SI; Chung CH; Yu KY; Kim SY
    Life Sci; 2014 Jul; 108(2):94-103. PubMed ID: 24880074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganoderma lucidum polysaccharide inhibits HSC activation and liver fibrosis via targeting inflammation, apoptosis, cell cycle, and ECM-receptor interaction mediated by TGF-β/Smad signaling.
    Chen C; Chen J; Wang Y; Fang L; Guo C; Sang T; Peng H; Zhao Q; Chen S; Lin X; Wang X
    Phytomedicine; 2023 Feb; 110():154626. PubMed ID: 36603342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β1/smad as Potential Anti-Hepatic Fibrosis Agents.
    You SP; Ma L; Zhao J; Zhang SL; Liu T
    Molecules; 2016 Jan; 21(1):102. PubMed ID: 26797590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schisantherin A ameliorates liver fibrosis through TGF-β1mediated activation of TAK1/MAPK and NF-κB pathways in vitro and in vivo.
    Wang H; Che J; Cui K; Zhuang W; Li H; Sun J; Chen J; Wang C
    Phytomedicine; 2021 Jul; 88():153609. PubMed ID: 34126414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling.
    Wu SM; Li TH; Yun H; Ai HW; Zhang KH
    Yonsei Med J; 2019 Jun; 60(6):561-569. PubMed ID: 31124340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
    Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
    Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
    Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
    Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways.
    Huang Q; Zhang X; Bai F; Nie J; Wen S; Wei Y; Wei J; Huang R; He M; Lu Z; Lin X
    Int Immunopharmacol; 2019 Jan; 66():41-51. PubMed ID: 30419452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.